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Abstract
Background
Down syndrome (DS) shows neuropathology similar to Alzheimer disease, which presents
olfactory impairment. Previous work showed olfactory impairment in DS, but a comprehen-
sive evaluation of olfactory function in DS is lacking.
Methods
We investigated a large number (n = 56; M = 31, F = 25) DS participants (age range18-57y)
using the “Sniffin’ Sticks” Extended test. This comprises three subtests (threshold, discrimi-
nation, and identification) yielding a global score (TDI) defining normosmia, hyposmia, and
functional anosmia. To the best of our knowledge, this is the second largest group of DS
people investigated for olfactory function ever. Age- and sex matched euploid individuals (n
= 53) were the control.
Results
In DS, TDI was lower (16.7±5.13 vs. 35.4±3.74; P<0.001), with DS people performing
worse in any subtests (P<0.001 for all); 27 DS participants showed functional anosmia (i.e.,
TDI<16). In DS, age was weakly and negatively correlated with TDI (r = -0.28, P = 0.036)
and identification (r = -0.34, P = 0.012). When participants were stratified in young adults
(18-29y) and older adults (30-61y), a significant effect of age was found for identification in
both DS (young adults, 8.3±2.58; older adults, 6.9±2.99; P = 0.031) and control (young-
adult, 14.3±1.18, older adult, 13.0±1.54; P = 0.016).
Conclusion
Olfactory function is overall severely impaired in DS people and may be globally impaired at
relatively young age, despite of reportedly normal smell. However, specificity of this olfac-
tory profile to DS should be considered with some caution because cognition was not
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evaluated in all DS participants and comparison with a control group of non-DS individuals
having cognitive disabilities was lacking. Further study is required to longitudinally assess
olfactory dysfunction in DS and to correlate it with brain pathology.
Background
In the brain of individuals affected with Down syndrome (DS), a trisomy 21 disorder, neurode-
generative changes take place, which are similar to those found in Alzheimer disease (AD)
namely, neuritic plaques, neurofibrillary tangles, amyloid deposits, cerebral atrophy, and loss
of presynaptic cholinergic markers [1–5]. In DS, deposition of amyloid in the form of senile
plaques or diffuse amyloid deposit has been found in cortical brain regions associated with
olfactory processing (e.g., entorhinal cortex) as early as the age of 19y [6–8]. Accordingly, olfac-
tory deficits have been described in AD [9] and DS since many years [10–13]; however, nasal
function in DS has been found to be comparable to controls [14] suggesting that olfactory defi-
cits are secondary to central-nervous rather than rhinological pathology.
Given the dramatic increase in prevalence and distribution of plaques by the third and
fourth decade of life in DS [15] and the progressive brain disease found in DS (similar to AD
[2]) it has been hypothesized that aging negatively affects the olfactory deficit in DS. This may
represent a serious issue for DS people, given their increase in longevity. In fact, early in this
century mean survival was 61.1y for males and 57.8y for females born with DS in Australia
[16] with the calculated mean age of death for children with DS being approximately 9y in
1933 [17]; at present, there may be over 210,000 people with DS over the age of 55 in the
United States of America [18]. Nevertheless, in a recent comprehensive review on aging in DS
[18] the olfactory deficit was not considered, suggesting that research is needed to explore the
pattern of olfactory function across the whole life span in DS. Actually, the number of studies
investigating olfactory function in DS is quite limited [12, 13, 14, 19, 20, 21, 22, 23, 24]; one
third of these papers [13, 20, 23] investigated to some extent the role of aging in the olfactory
deficit of DS. Moreover, most studies are focused on individual aspects of olfactory function
thereby lacking a comprehensive evaluation.
In the clinical setting, the complexity of olfactory function may be assessed with non-inva-
sive psychophysical tests exploring performance in specific olfactory tasks (e.g., odor detection,
discrimination, identification, memory, suprathreshold intensity). Importantly, these different
olfactory tests seem to tap into different functions of the olfactory system [25, 26]. Accordingly,
in this study we jointly measured olfactory threshold, olfactory discrimination, and olfactory
identification performance in each participant by means of a standardized test battery.
The test yields a global score, the TDI score (= threshold score + discrimination score
+ identification score) allowing for detection of normosmia (TDI30.3), hyposmia
(30.3>TDI16), and functional anosmia (TDI<16). Kobal et al. introduced the term “func-
tional anosmia” in 2000. This definition means that subjects with a TDI score below 16 are
considered to be completely anosmic or to have some olfactory function left, which is not
useful in daily life [27]. Indeed, a subject with functional anosmia may still perceive few
odors, discriminate between some of them or show olfactory event-related potentials [28];
however, this residual olfactory function does not contribute to the enjoyment of food/drink
or to the detection of spoiled food or gas leaks. The above procedure was validated on more
than 3000 healthy subjects [27] and it is widely used in Europe but, to our knowledge, it has
never been used in DS individuals.
Olfaction in Down Syndrome
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In the current work, such a comprehensive evaluation of olfactory function was carried out
in a large sample of DS people and age-matched euploid controls over an age range of four
decades with a two-fold aim: first, to investigate olfactory function in DS; second, to study the
possible age-related impairment of olfactory function in DS. Given the above mentioned
increase in prevalence and distribution of amyloid plaques by the third and fourth decade of
life in the DS brain [15] the effect of age on olfactory tests performance was assessed by stratify-
ing the sample into two age groups: young-adult (age range, 18-29y) and older-adult (age
range, 30-61y). The effect of sex (M, F) was assessed as well.
Methods
Participants
DS individuals were recruited through public and private organizations working in the field of
mental disability. Inclusion criteria were age18y, overall good health, ability to comprehend
and perform adequately the test procedure. Exclusion criteria were presence of pathology able
to affect olfactory performance (e.g., recent head trauma, rhinitis or chronic sinus infection,
diabetes, stroke, thyroid dysfunction, history of smoking/alcohol). The study protocol and the
olfactory test procedures were illustrated to DS individuals and/or guardians, and written
informed consent obtained. Control subjects were recruited through public advertisement. All
investigations were carried out in accordance with the Helsinki Declaration and the protocol
was approved by the relevant IRB at the University of Verona (Prot. N. 102, 3rd April 2012,
TIT.11/9).
Prior to olfactory testing all participants were asked to rate their olfactory function and the
answer (better than normal, normal, less than normal) was registered.
Procedures
Olfactory testing was carried out in a well-ventilated room using the “Sniffin’ Sticks” Extended
test (Burghart, Wedel, Germany). This is a test of nasal chemosensory performance based on
pen-like odor dispensing devices with a felt-tip (length 14 cm, diameter 1.3 cm). Instead of liq-
uid dye, the pen's tampon is filled with 4 ml of a given liquid odorant or odorant dissolved in
propylene glycol. The test consists of three subtests namely, threshold (the concentration at
which the odor is reliably detected), discrimination (the ability of the subject to distinguish
odors) and identification (the subject has to identify 16 different odors from a list of 4 odors
each). In order to increase the reliability of the measurements, each subject must give an answer
(forced choice paradigm). During each subtest, the experimenter removes the cap of the pens
and the pen's tip is held approximately 1 cm under both nostrils for around 3 seconds. Patients
are tested blindfolded with a sleeping mask to prevent visual identification of the odorant-con-
taining pens for threshold and discrimination test.
The threshold subtest uses n-butanol as target odor (ink pen odor). Threshold is assessed
using a staircased, three alternative forced choice procedure (3-AFC procedure). It consists of
sixteen dilutions, prepared in a geometric series starting from a 4% n-butanol solution (dilution
ratio 1:2 in deionized water as solvent). Three pens are presented in randomized order, with
two containing the solvent and one containing the odorant. Subjects are asked to identify the
odor-containing pen. Reversal of the staircase (i.e. the presentation of the triplet with the next
lower odor concentration) is started when the odor-containing pen is correctly identified in
two successive trials. When subjects give an incorrect answer, the triplet with the next higher
odor concentration is presented and thus, the staircase is reversed. Testing is completed after
seven reversals of the staircase. Odor threshold is defined as the mean of the last four out of
seven staircase reversals.
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The discrimination subtest also uses a 3-AFC procedure: triplets of pens are presented in
randomized order, with two containing the same and one a different odorant. Subjects have to
determine which of the three pens smells different than the other two pens. For threshold and
discrimination subtest the presentation of triplets is separated by 30 seconds. The interval
between administrations of individual pens is approximately 3 seconds.
The identification subtest is assessed for 16 common odors (e.g., orange, peppermint, coffee,
fish, banana). Immediately before the odor is presented, the examiner reads a list of four
response options from which the subject has to choose the correct answer. The subject is asked
to choose one answer option that s/he feels to be correct after the odor had been presented,
having also the possibility to read a paper words list and look at pictures of the four choice
options each time, before and after the odor presentation [29, 30]. The interval between odor
presentations is approximately 30 seconds. The decision to add to the paper words list odor’s
pictures was adopted to give a support in words’ meaning comprehension to the DS subjects
[31]. This olfactory task with pictures seems to be particularly appropriate for children and for
individuals with mental disability as reported in [23]. We used pictures taken from various
sources [freely available on www.google.it/] because a validated olfactory identification test
with pictures corresponding to the Burghart identification odors did not exist.
Overall, 60 persons with DS were recruited. Four participants were discarded due to a family
consent refusal a priori or because of going-on difficulties arisen during the procedure. Data
from a final group of 56 DS participants (31 M; 25 F), age range 18-57y were used for analysis.
A group of euploid participants (n = 53; M = 23, F = 30, age range: 18-61y) fulfilling the same
inclusion and exclusion criteria were used as control.
For a subset of DS participants (n = 13; 5M, 8F, mean age: 26.4±4.19y, age range: 18-33y) cog-
nitive evaluation was available. An expert psychologist tested cognition with theWechsler Adult
Intelligence Scale-Revised (WAIS-R). This scale consists of six verbal and five performance sub-
tests. The verbal tests are: Information, Comprehension, Arithmetic, Digit Span, Similarities,
and Vocabulary. The Performance subtests are: Picture Arrangement, Picture Completion,
Block Design, Object Assembly, and Digit Symbol. Thus, a Verbal Intelligence Quotient (VIQ),
Performance Intelligence Quotient (PIQ), and full scale IQ were available (TIQ).
Data analysis
Normal distribution of the data was assessed using the Shapiro-Wilk test. The following vari-
ables were approximately normally distributed: discrimination, identification, and TDI.
Threshold, VIQ, PIQ, and TIQ variables had a non-normal distribution; accordingly, nonpara-
metric statistical methods were adopted in the analysis of these variables. Numerical variables
were summarized using mean, standard deviations (SD) or median, Inter-Quartile Range
(IQR) as appropriate. Student t test and chi-square (χ2) test were used to compare mean age
and the proportion of females in the DS and control group, respectively.
Three-way ANOVA was used to investigate the differences in discrimination, identification,
and TDI between the 8 groups identified by three binary factors: DS/control, M/F, and age
class (young adult, age range 18-29y; older adult, age range 30-61y). The same analysis was per-
formed for threshold using median regression with interactions terms (and sum-to-zero coding
for factors). Eta-squared (η2) estimates of effect size were reported for the main effects of each
factor, together with F statistics (t statistics for threshold) and P-values. The mean differences
in olfactory tests by sex and age were also investigated in control and DS separately using linear
regression (median regression for threshold). Wald test on linear and median regression coeffi-
cients was performed to evaluate the significance of these differences (t statistic is reported
with P-value).
Olfaction in Down Syndrome
PLOSONE | DOI:10.1371/journal.pone.0146486 January 5, 2016 4 / 13
Correlation was assessed using the Pearson’s correlation coefficient (r) or the Spearman’s
rank correlation coefficient (ρ) where appropriate. Nonparametric estimates of the area under
the ROC curve (AUC-ROC) were calculated to assess the ability of olfactory tests in discrimi-
nating DS from controls.
Differences were considered significant at P0.05. Statistical analyses were performed using
Stata 13 (StataCorp, College Station, TX).
Results
Characteristics of the participants
The demographic data for the participants are reported in Table 1 together with the relevant
statistics.
The DS and control groups were not significantly different for age and sex. All participants
reported to have a normal sense of smell. The experimenter administering the olfactory test
noted no difficulties with sniffing performance in any subjects. No signals of fatigue in the
course of the experiment were noticed. None of the participants was taking drugs that are
known to have an influence on olfactory perception. The TDI score was above the threshold
for normosmia (i.e., 30) in all but one euploid participant. Instead, 27 DS individuals (20M, 7F)
out of 56 showed functional anosmia (i.e., TDI<16).
Differences in olfactory tests performance—DS/controls
ANOVA showed that mean TDI score was 16.7±5.13 (range 5.0–27.5) in DS and 35.4±3.75
(range 27.2–46.0) in control group (F(1,101) = 422.49;P < 0.001; η2 = 0.81). The DS group
performed significantly worse than controls in any subtests: threshold, 2.1 (IQR = 1.0–4.1)
vs. 8.3 (IQR = 6.5–9.7) (t(101) = -10.18; P< 0.001; η2 = 0.53); identification, 7.8±2.81 vs. 13.9
±1.45 (F(1,101) = 179.11;P < 0.001; η2 = 0.64); discrimination, 5.9±1.97 vs. 13.0±1.77 (F
(1,101) = 343.84; P<0.001; η2 = 0.77). Using linear regression models, further analysis was
conducted in each age class (young adult, older adult) adjusting by sex. A significant differ-
ence was found for any subtests and for TDI with P<0.001 for all: identification in young
adults (DS = 8.4±2.58 vs. control = 14.4±1.18; t(65) = -12.18) and in older adults (DS = 6.9
±2.99 vs. control = 13.1±1.54; t(38) = -7.97); threshold in young adults [DS = 2.3 (IQR 1.0–
4.3) vs. control = 8.1 (IQR 6.5–9.5); t(65) = -7.20) and in older adults [DS = 1.9 (IQR 1.0–3.5)
vs. control = 8.5 (IQR 6.8–10.5); t(38) = -6.24]; discrimination in young adults (DS = 5.9
±1.92 vs. control = 13.3±1.59; t(65) = -17.07) and in older adults (DS = 5.9±2.09 vs. con-
trol = 12.3±1.95; t(38) = -10.15); TDI in young adults (DS = 17.4±5.16 vs. control = 36.0
±3.52; t(65) = -17.42) and in older adults (DS = 15.6±5.01 vs. control = 34.4±3.99; t(38) =
-13.36). Results are shown in Fig 1. The ability of olfactory tests in discriminating DS from
control was excellent (AUC-ROC>0.90 for all). TDI showed the highest predictivity; for a
threshold value TDI<27.5, overall accuracy, sensitivity and specificity were 99.1%, 100%, and
98.1%, respectively.
Differences in olfactory tests performance—Age
ANOVA showed a significant main effect of age for odor identification in the whole cohort
(young adult 11.4±3.62; older adult 9.8±3.92; F(1,101) = 6.78, P = 0.011; η2 = 0.06). Non-signif-
icant differences were found for threshold [5.9 (IQR = 1.9–8.6) vs. 5.8 (IQR = 1.5–8.5); t(101) =
0.90, P = 0.368; η2 = 0.10], discrimination (9.6±4.11 vs. 8.9±3.80; F(1,101) = 1.34; P = 0.250;η2
= 0.01), and TDI (26.7±10.33 vs. 24.3±10.47, F(1,101) = 1.52, P = 0.212; η2 = 0.01). Using linear
regression models, further analysis was conducted in each group (DS, control) by age class
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(<30y,30y) adjusting by sex. Results are shown in Fig 1. A significant effect of age class was
found for identification in both the DS (young adult, 8.3±2.58; older adult, 6.9±2.99; t(53) =
-2.21, P = 0.031) and control (young adult, 14.3±1.18, older adult, 13.0±1.54; t(50) = -2.49,
P = 0.016) groups.
Differences in olfactory tests performance—Sex
When sex (M, F) was considered in the whole cohort, a significant main effect was found for
TDI (M = 23.3±10.43, F = 28.2±9.86; F(1,101) = 9.44, P = 0.003; η2 = 0.09) and threshold
(M = 3.5 [IQR = 1.3–7.5], F = 6.8 [IQR = 3.8–9.5], η2 = 0.06; t(101) = 3.39, P = 0.001), with dif-
ference in discrimination (M = 8.6±4.18, F = 10.0±3.71,; F(1,101) = 3.50, P = 0.064; η2 = 0.03)
and identification (M = 10.0±3.91, F = 11.5±3.55; F(1,101) = 3.65, P = 0.059; η2 = 0.03) being at
the limit of statistical significance. The role of sex was also investigated in the control and DS
group separately by regression analysis, adjusting by the effect of age. A significant difference
was found for identification (M = 13.5±1.50, F = 14.2±1.35; t(50) = 2.58, P = 0.013) in the con-
trol group, as well as TDI (M = 15.2±4.94, F = 18.6±4.80; t(53) = 2.52, P = 0.015), threshold
(M = 2.3±2.07, F = 3.9±2.85; t(53) = 3.08, P = 0.003), and discrimination (M = 5.5±2.09,
F = 6.4±1.73; t (53) = 3.42, P = 0.001) in the DS group.
Correlational analysis
In the whole cohort (n = 109), age weakly and negatively correlated with the scores of all olfac-
tory tests; statistical significance was found for TDI (r (107) = -0.19, P = 0.044) and identifica-
tion (r (107) = -0.24, P = 0.012); after adjusting for sex, odor identification only retained
significance (r (106) = -0.20, P = 0.038). In the DS group (n = 56), age showed weakly signifi-
cant negative correlation with TDI (r (54) = -0.28, P = 0.036) and identification (r (54) = -0.34,
P = 0.012); correlation with threshold (ρ (54) = -0.11, P = 0.431) and discrimination (r (54) =
-0.04, P = 0.784) was not significant. After adjusting for sex, identification only retained signifi-
cance (r (53) = -0.30, P = 0.026). In the control sample (n = 53), similar result was found for
TDI (r (51) = -0.28, P = 0.042) and threshold (ρ(51) = -0.02, P = 0.898); the correlation between
age and discrimination was weakly significant (r (51) = -0.27, P = 0.050) and borderline signifi-
cant for identification (r (51) = -0.25, P = 0.066). After adjusting for sex, no correlation retained
significance.
In the subset of DS patients undergoing the WAIS-R test, weak to moderate positive correla-
tions were found between scores in olfactory and cognitive tests (Table 2). In particular, statisti-
cally significant correlations were found between discrimination, identification and TDI, and
VIQ and full IQ.
Table 1. Demographic characteristics of participants. Means are ± SD.
Characteristic Down syndrome Control Test on Difference§
(n = 56) (n = 53)
Sex χ2 (1,N = 109) = 1.56; P = 0.212
M 31 (55.4%) 23 (43.4%)
F 25 (44.6%) 30 (56.6%)
Age (y) 30.1±10.74 28.3±11.08 t(107) = -0.86; P = 0.394
§ = chi-square test for Sex and Student’s t-test for Age
doi:10.1371/journal.pone.0146486.t001
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Fig 1. Mean scores (with 95% confidence intervals) estimated for DS individuals (DS) and euploid
controls (C) in each olfactory subtest (threshold, discrimination, identification), and the global test
(TDI) according to age class (young adult [<30y], left panel; older adult [30y], right panel).Olfactory
performance (adjusted by sex) was significantly lower in DS than controls for any tasks and TDI in both age
classes (P<0.001 for all, black bars). Identification score was significantly higher in young adults than older
adults both for controls (P = 0.016) and DS (P = 0.031, red bars).
doi:10.1371/journal.pone.0146486.g001
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Discussion
This work investigated in some detail the olfactory function in the second largest sample of
people with DS ever. Data were obtained across about four decades of age, and compared with
those from age- and sex-matched euploid individuals. Results demonstrate the following
points:
1. The overall olfactory function (odor threshold, odor discrimination, odor identification) is
severely impaired in both young-adult (<30y) and older-adult (>30y) DS individuals.
2. Aging is associated with limited loss of olfactory function, especially odor identification.
A first finding of this study is that olfactory threshold, olfactory discrimination and olfac-
tory identification are all severely impaired in DS. Since all DS subjects reported to have a nor-
mal sense of smell, it is apparent that they are not aware of their olfactory status. Therefore, it
is important that DS subjects and caregivers are educated to appreciate the relevance of olfac-
tion in daily life, especially in recognizing dangerous odours (e.g. gas, smoke or spoiled food).
However, similar to what is known from patients with disorders leading to a gradual smell loss
(e.g. Alzheimer’s or Parkinson’s disease [32]), there is also a large number of healthy adults
with a slowly progressive olfactory dysfunction unaware of their deficit [33] and, in conse-
quence, the presence of olfactory dysfunction is often underestimated in the general population
[34, 35]. Accordingly, DS per semay be not the only determinant of the lack of awareness of
smell deficit in DS participants. In this study, the relative contribution of DS status and the pro-
gressive olfactory dysfunction found in the general population was not assessed.
The current results are supported by previous work showing, in nine adult (average age
25.9y) DS individuals, a 44% lower performance in the University of Pennsylvania Smell Iden-
tification Test (UPSIT) [36] vs. matched controls [19]. Similarly, UPSIT performance was 47%
lower in twenty younger DS persons/individuals (mean age 20.0±2.3y) vs. euploid matched
controls [13]. In a study involving 23 DS individuals (30.1±7.2y, range 25-46y) Murphy and
Jinich (1996) found a 47% lower performance in UPSIT vs. euploid matched controls; more-
over, using n-butyl alcohol as the stimulus, Murphy and Jinich (1996) showed that mean
odour detection threshold was sharply lower in DS than control (dilution step 5.0 vs. 8.6). In
the largest study to date, involving 67 DS individuals (age range from 7–50 years), Nijar and
Murphy (2002) investigated odor threshold (n-butyl alcohol dilution test) and odor identifica-
tion (San Diego Odor Identification Test, SDOIT [37] and UPSIT) in DS vs. normal individuals
and mentally retarded subjects. Nijar and Murphy (2002) found generally poorer performance
Table 2. Pairwise correlations (threshold: Spearman’s ρ; discrimination, identification, and TDI: Pear-
son’s r) between olfactory and cognitive tests in DS individuals (n = 13).
WAIS-R
Olfactory test VIQ PIQ TIQ
Threshold 0.36 0.09 0.21
Discrimination 0.66* 0.33 0.57*
Identiﬁcation 0.57* 0.42 0.64*
TDI 0.78** 0.40 0.68*
VIQ, Verbal Intelligence Quotient; PIQ, Performance Intelligence Quotient; TIQ, full scale Intelligence
Quotient; TDI, sum of threshold, discrimination, and identiﬁcation scores
*, P <0.05;
**, P <0.01
doi:10.1371/journal.pone.0146486.t002
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in DS at the child (7-17y), young-adult (18-29y), and adult (30-50y) age level. For example,
odor threshold was 44% and 46% lower in young-adult and adult DS individuals vs. normal
controls. In SDOIT, the mean percentage of correctly identified odors was 62.5% and 96% in
the DS and normal control group, respectively; for UPSIT, performance was markedly worse in
DS vs. normal controls at the three age levels. In the present study, we used the validated [27]
“Sniffin’ Sticks” Extended Test exploring odor threshold, odor discrimination, and odor identi-
fication to confirm and expand on previous results by showing that the DS group generally per-
formed worse than euploid controls (threshold, -65%; discrimination, -55%; identification,
-44%; TDI, -53%).
A novel finding of the present work is that olfactory discrimination is impaired in DS. To
our knowledge, olfactory discrimination has never been assessed in DS but in a single study
[21]. In this study, 20 young DS adolescents (average age 13 years) were evaluated with a 16
items three choice test, scratch and sniff method, and findings showed lower mean perfor-
mance in DS adolescents vs. age-matched controls, but the difference was not statistically sig-
nificant. While the limited number of participants in this study may have prevented statistical
significance, the reported absence of AD related pathology in early teens might play a role, sup-
porting the speculation by McKeown and colleagues that DS related olfactory dysfunction
occurs only at ages when AD-like pathology is present and/or for an initial period of time brain
compensatory mechanisms operate preserving olfactory function. In our study, the minimum
age for inclusion was 18y, thereby preventing assessment of olfactory function in younger DS
individuals; however, we found that in DS young adults (18-29y) olfactory discrimination is
impaired (as well as olfactory threshold and olfactory identification), suggesting that olfaction
in DS is overall impaired at relatively young age. Further work involving e.g. structural and
functional magnetic resonance imaging is required to more precisely correlate olfactory dys-
function and brain pathology in DS.
The evidence for age-related deficits in olfaction is overwhelming [27] (for a recent review
see [38]), the cause being manifold and involving both neural and non-neural factors. In DS,
an increased risk of several chronic diseases that are typically associated with older age is pres-
ent. This may be due to the ability of trisomy 21 to accelerate aging, for example by increasing
the biological age of tissues [39].
Earlier work carried out in 20 DS individuals (including 9 older subjects with mean age 32.2
±7.10y) showed a trend for increased olfactory identification deficit with age [13]. While the
small number of participants may have affected significance, these findings could indicate that
the age effect on olfactory deficit is fully expressed at age>30y. In this work we examined a
sample of DS individuals including about 40% of individuals aged 30+y and found moderate,
negative correlation between age and olfactory performance as well as a significant effect of
age class (<30y,30y) for identification. Similar results were found in age-matched controls.
Accordingly, it is suggested that the age-associated olfactory deficit roughly parallels in DS and
euploid individuals, with odor identification being mainly affected by age. These findings are
supported by previous data showing poorer performance of 14 older DS persons (mean age 41
±6.8y, range 32-54y) vs. younger DS subjects aged 26.5±3.0y (range 20-31y) in an olfactory
naming task [20]; in a larger number of adult (n = 26, mean age 38.8±7.1y) and young-adult
(n = 23, mean age 23.2±4.0) DS individuals Nijjar and Murphy (2002) showed a non-signifi-
cant trend for reduced odor threshold in the former and a significant reduction of picture-
based odor identification.
Although not within the main focus of this investigation, a further result of this work is that
females with DS have less impaired olfactory function than males over a large age range. The
question as to whether olfactory performance is to some extent sex-related, similar to percep-
tual motor or verbal tasks, has been debated for decades. Investigation of sex difference in
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olfactory threshold (i.e., olfactory sensitivity) yielded an overall evidence for females being
more sensitive than males for some odorants (reviewed in [40]). The evidence in favour of
females’ better performance in odor identification is more consistent, with several studies
showing superior female performance in identifying every day’s life common odors as well as
human body odors [40]. Using the “Sniffin’ Sticks” Extended test, Hummel et al. (2007) found
that, in 3282 male and female subjects, female outperformed males in the three olfactory tests.
In this work we showed that DS females have significantly higher TDI score (an estimate of
overall olfactory function) than DS males, suggesting that the neurobiological basis for better
olfactory function in females is not affected by trisomy 21.
A first limitation of this work is that cognition was not evaluated in all DS participants.
Accordingly, the effect of mental retardation on olfactory performance could not be evaluated
in full. A second limitation of our work is the lack of comparison with another control group
with non-DS individuals having cognitive disabilities. This would support the specificity of this
olfactory profile to DS.
Assessment of olfactory threshold, discrimination and identification allows a measure of
the integrity of the olfactory function. In spite of this, it is important to mention that also the
personal cognitive profile has an influence on higher order olfactory performance [41,42].
Odor detection does contribute to the odor-identification deficit, but does not account for it
completely [43] indicating that odor threshold taps into a different olfactory domain compared
to odor identification and odor discrimination (see also [1,2]).
However, WAIS-R measurements positively correlated with tests of olfactory performance
in the subsample where this information was available (Table 2), in agreement with previous
work showing significant positive correlation between UPSIT scores and Dementia rating Scale
in DS [12]. In particular, the statistically significant correlation we found between higher order
olfactory performances and VQI, even if in a small sample of subjects, supports previous stud-
ies showing that there is a positive relation between proficiency in semantic tasks with an
important verbal component, and both discrimination and identification tasks [25, 42, 44].
Interestingly, the strength of correlation was definitely lower for threshold than identification,
discrimination, and TDI. An explanation for this finding is that in threshold test, although a
3-AFC paradigm is used, the pen containing the odor may be easily identified. In contrast, dur-
ing odor discrimination testing, the subject has to memorize the smell of the other two pens
before completing the task. Memory of odors is even more so required during odor identifica-
tion test [26]. During the odor identification process, detection, discrimination, recognition
and retrieval of an odor name are involved [9, 25, 45, 46]. Moreover, it is important to mention
that previous studies revealed that DS individuals have relatively poor explicit memory ability
when compared to control subjects, even using olfactory stimuli (see [47]). So, the influence of
memory might be a significant factor to be considered in DS people. Therefore, odor discrimi-
nation and odor identification appear to involve higher-level cognitive functions compared to
odor thresholds, and it may be hypothesized that the reported effects relate to the interaction
between cognitive and olfactory function. Accordingly, odor identification and discrimination
appear to be not only an indicator for olfactory function but also for cognitive abilities.
It is interesting to note that the amyloid precursor protein (APP) gene is located on chromo-
some 21. This gene encodes the transmembrane protein APP, from which Amyloid β is pro-
duced. The extra copy of APP gene is believed to lead to overproduction of Amyloid β peptides
in DS [48]. This appears to be critical for the development of AD. Thus, the features of AD in
DS individuals could be present 20–30 years earlier. Accordingly to the above, this “accelerated
degeneration process” in DS could explain for example the global olfactory tasks deficit. Evi-
dence suggests that in early phases of AD, olfactory impairment is addressed on more cogni-
tively driven tasks (i.e. discrimination and identification), while odor threshold is spared [49].
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In DS also odor threshold is severely impaired, even in people under 30y. Since odor threshold
has been shown to correlate with the olfactory bulb volume [50], and olfactory bulb is the first
central relay station of the peripheral olfactory neurons, it is possible that in DS the fast degen-
eration process leads to a severe deficit even at a relatively young age also on olfactory tasks of
lower cognitive order such as odor threshold. However, in the absence of neuropathological
data relating neurodegeneration and olfactory function in DS, the above considerations remain
speculative.
Conclusion
The current study investigated olfactory function over four decades of age in a large adult pop-
ulation with DS assessing olfactory threshold, olfactory identification and, for the first time,
olfactory discrimination. It was apparent that, despite of reportedly normal smell, olfactory
function is overall severely impaired in DS people group, such an impairment appearing at rel-
atively young age. Accordingly, DS people and caregivers should better appreciate the relevance
of olfaction in recognizing e.g., dangerous odors. In a subsample of participants, olfactory per-
formance correlated with cognitive performance, indicating interaction between cognitive and
olfactory function. Further studies are required both to compare olfactory and cognitive perfor-
mances also in a group of non-DS individuals with cognitive disabilities and to further investi-
gate olfactory system by e.g., nasal brushing and magnetic resonance imaging in order to
correlate clinical findings with brain pathology insofar the olfactory deficit may represent an
early indicator of neurodegenerative events occurring in the DS brain.
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